First Published: 15 Jul 2020

Custom Pharma Services are supporting research dedicated to understanding COVID-19 and improving the outcome for patients.

University of Oxford decided to use Custom Pharma’s expertise and awarded Custom Pharma the manufacture for clinical trial of a new clinical drug, which could lead to enhanced respiratory care for patients and aimed at treating COVID-19, funded by LifeArc: